Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04836208
Other study ID # 2020-059
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 30, 2021
Est. completion date May 2023

Study information

Verified date September 2022
Source Institut Pasteur
Contact Bich-Tram Huynh, MD
Phone +33 1 45 68 83 01
Email bich-tram.huynh@pasteur.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Enterobacteriaceae, more specifically Escherichia coli and Klebsiella pneumoniae, are the bacteria most often responsible for neonatal infections in low-income countries. Infections caused by multidrug-resistant Enterobacteriaceae: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), are more often associated with an unfavorable outcome of the infection. Enterobacteriaceae colonize the digestive tract which is the first step in developing a potential infection. Very few studies have been carried out at the community level. Colonization of the mother with ESBL-E is generally considered to be a major route of acquisition. The carrying of ESBL-E by other family members and other potential sources of transmission (food, objects and surfaces in contact with the newborn) have never been documented. In addition, with a view to offering an intervention adapted to the local context, the local cultural determinants which govern the interactions of the newborn with his environment are important to understand.


Description:

This is a single-center prospective cohort of all members living in the same household in which a newborn baby has just been born. The study consists to: - recruit a cohort of all members of 60 households in which a newborn has just been born - carry out semi-structured interviews and direct participant observation. This study is divided in two parts : - the epidemiological part : the documentation of colonization by E-ESBL by sampling the stools of the newborn, of all members of the household, and sampling of food given to the child, from surfaces in contact with it. - the anthropological part : Semi-structured interviews with key people in the structuring of the social and family environment of the newborn and participant direct observation of households.


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date May 2023
Est. primary completion date May 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. For the epidemiological study : All members of 60 households in which a newborn baby has just been born Inclusion criteria for the mother at the time of childbirth, pregnant woman : _ having a monofetal pregnancy - residing regularly in the study area OR planning to reside in the study area during the study period; - having been informed of the research and collection of biological samples on herself and her newborn; - having given its agreement to carry out the research and the associated collection of biological samples, and; - having signed the informed consent (or its witness if applicable). Inclusion criteria for the live newborn at the time of childbirth, new born : - living after childbirth; - whose parents or legal representatives present: - reside regularly in the study area or plan to reside in the study area during the study period; - were informed of the research and the associated collection of biological samples on their newborn; - have given their agreement to carry out the research and the associated collection of biological samples, Inclusion criteria for the household member, resident: - from the same household as the mother-child (ren) couple included - Residing at least 4 nights per week in this home - Having given its agreement to carry out the research and the associated collection of biological samples, - and having signed the consent of the study (or its witness, or its legal representative if applicable) 2. for the anthropological study with interviews : 16 homes will be selected from among the 60 homes included: 8 homes in which the child has not acquired an ESBL-E during the entire follow-up and 8 homes in which the child has acquired an ESBL-E at least once during its follow-up. Among these households, interviews will be carried out with: 16 mothers or first responsible for the child in the absence of the mother 4 people with a mothering role on the child (grandmother, aunts ...) 4 minors in the families to observe 4 fathers or father figures in families to observe Also, interviews will be done with: Health actors: medical (1 midwife and 1 neighborhood doctor) and traditional (1 matron and 1 traditional practitioner from the neighborhood), 1 community health worker 1 neighborhood chief Inclusion criteria for semi-structured interviews : - people responding to the structuring functions of the child's social and family environment - Having given its agreement to carry out the research, - and having signed the consent of the study (or its witness, or its legal representative if applicable) For health workers and district managers, inclusion criteria for semi-structured interviews : - people responding to the targeted functions - working in the district of homes included - Having given its agreement to carry out the research, - and having signed the consent of the study (or its witness, or its legal representative if applicable) 3. For the anthropological study with observations 4 households in total among the 16 initially selected for the interviews: 2 households in which the child did not acquire ESBL-E during all the follow-up and 2 households in which the child acquired at least once an BLSE-E during his follow-up Inclusion criteria for participating direct observations - Residents of the same household as the mother-child (ren) couple included - having agreed to participate in the study - Having given its agreement to carry out the research, - and having signed the consent of the study (or its witness, or its legal representative if applicable) Exclusion Criteria: 1. For the epidemiological part: - Pregnant woman: non-monofetal pregnancy - Newborn: died during childbirth - Household resident: None 2. and 3) For the anthropological part: • Semi-structured interview: For household members: - not responding to the structural family and social functions of the child's environment For health workers and district managers - people not meeting the targeted functions - not practicing in the district of homes included • Participant direct observation: - Not living in the same household as the mother-child couple included

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Madagascar Institut Pasteur de Madagascar Antananarivo

Sponsors (3)

Lead Sponsor Collaborator
Institut Pasteur Centre hospitalier de référence du District de Moramanga, Institut Pasteur de Madagascar

Country where clinical trial is conducted

Madagascar, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of acquisition events and the number of non-acquisition of E-ESBL in newborns for the epidemiological part Identification of bacterial strains from stool and sequencing of EBSL-E strains 2 years
Primary Number of semi-structured interviews completed for the anthropological part 1 or 4 hours semi-structured interviews of participants at home done by investigators 2 years
Primary Number of participant direct observation completed for the anthropological part observations of the participants at home done by investigators (2 to 4 hours in 3 to 4 sessions over 28 days) 2 years
See also
  Status Clinical Trial Phase
Completed NCT02400268 - Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae Phase 3
Completed NCT03401242 - Prevalence of ESBL and CPE in French Nursing Homes
Not yet recruiting NCT03967301 - Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics N/A
Completed NCT02795949 - Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae Phase 3
Completed NCT00573235 - Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
Recruiting NCT00404625 - Infections Caused by ESbL-Producing Enterobacteriaceae in Italy N/A
Completed NCT00573521 - Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
Recruiting NCT03671967 - PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) Phase 4
Enrolling by invitation NCT03924934 - Community-associated Highly-Resistant Enterobacterales
Completed NCT03477084 - Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
Not yet recruiting NCT05632315 - PMT for MDRO Decolonization Phase 2
Withdrawn NCT03527056 - Pilot Study Using Oral Capsule FMT to Decolonize GI CRE Early Phase 1
Completed NCT00826670 - Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study Phase 4
Not yet recruiting NCT04903886 - Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
Completed NCT02482051 - Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
Recruiting NCT00894036 - The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children N/A
Suspended NCT05355350 - PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections Phase 4
Recruiting NCT05516433 - Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
Recruiting NCT02450942 - 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection Early Phase 1
Recruiting NCT05035342 - Fecal Transplantation to Eradicate Colonizing Emergent Superbugs Phase 3